Dynavax Technologies Corp (NDAQ:DVAX) | Stock Discussion (2024)

Post by wmcveyon Dec 11, 2020 12:04pm

Hep-b approval and Corona vaccine trial updates imminent

More than doubling of the Hep-B vaccine market, Dynavax's primary revenue source, looks very likely:https://www.prnewswire.com/news-releases/european-chmp-adopts-positive-opinion-for...more

Post by wmcveyon Aug 14, 2020 5:25am

$3.5 mil grant from bill and milinda gates foundation

https://www.globenewswire.com/news-release/2020/08/13/2077857/0/en/Dynavax-Announces-Grant-to-Scale-up-CpG-1018-Adjuvant-Capacity-to-Support-the-Global-COVID-19-Response.html This news alongside...more

Dynavax Technologies Corp (NDAQ:DVAX) | Stock Discussion (2024)

References

Top Articles
Latest Posts
Article information

Author: Terence Hammes MD

Last Updated:

Views: 6014

Rating: 4.9 / 5 (49 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Terence Hammes MD

Birthday: 1992-04-11

Address: Suite 408 9446 Mercy Mews, West Roxie, CT 04904

Phone: +50312511349175

Job: Product Consulting Liaison

Hobby: Jogging, Motor sports, Nordic skating, Jigsaw puzzles, Bird watching, Nordic skating, Sculpting

Introduction: My name is Terence Hammes MD, I am a inexpensive, energetic, jolly, faithful, cheerful, proud, rich person who loves writing and wants to share my knowledge and understanding with you.